- Home
- EXLS vs FOLD Comparison
EXLS vs FOLD Comparison
Compare EXLS & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXLS | FOLD |
|---|---|---|
| Founded | 1999 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.5B |
| IPO Year | 2004 | 2006 |
Fundamental Metrics
Financial Performance| Metric | EXLS | FOLD |
|---|---|---|
| Price | $29.64 | $14.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $46.80 | $27.25 |
| AVG Volume (30 Days) | 2.3M | ★ 3.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.27 | ★ 50.00 |
| EPS | ★ 1.54 | N/A |
| Revenue | ★ $2,087,679,000.00 | N/A |
| Revenue This Year | $12.85 | $20.50 |
| Revenue Next Year | $10.65 | $18.59 |
| P/E Ratio | $19.30 | ★ N/A |
| Revenue Growth | ★ 13.56 | N/A |
| 52 Week Low | $26.94 | $5.66 |
| 52 Week High | $48.79 | $14.39 |
Technical Indicators
Market Signals| Indicator | EXLS | FOLD |
|---|---|---|
| Relative Strength Index (RSI) | 33.93 | 69.55 |
| Support Level | $28.62 | $14.21 |
| Resistance Level | $43.51 | N/A |
| Average True Range (ATR) | 1.16 | 0.02 |
| MACD | 0.23 | -0.02 |
| Stochastic Oscillator | 43.29 | 78.57 |
Price Performance
Historical ComparisonAbout EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.